RecruitingNCT07559695
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
Studying Multiple endocrine neoplasia type 1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The First Affiliated Hospital of Soochow University
- Principal Investigator
- Su-ning Chen, M.D.The First Affiliated Hospital of Soochow University
- Enrollment
- 20 target
- Eligibility
- 15 years · All sexes
- Timeline
- 2025 – 2029
Study locations (1)
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07559695 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia type 1
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06430021Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 MutationCentre Hospitalier Universitaire Dijon
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04530916Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal WomenColorado State University
- RECRUITINGNCT03966612Study and Monitoring of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- RECRUITINGNCT03348501Study and Follow-up of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- ACTIVE NOT RECRUITINGNCT03048279Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2M.D. Anderson Cancer Center